1887

Chapter 21 : Measles, Mumps, and Rubella Viruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Measles, Mumps, and Rubella Viruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch21-1.gif /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch21-2.gif

Abstract:

Measles virus is a single stranded, nonsegmented, negative sense RNA virus and the prototypic member of the genus of the subfamily of the The standard viral genome is 15,894 nucleotides in length and contains six genes and encodes eight proteins which include nucleoprotein (N), phosphoproteins (P) C and V, and matrix (M), fusion (F), hemagglutinin (H), and polymerase (L) proteins. The measles virion is spherical with a diameter ranging from 120 to 250 nm. The virus buds from the plasma membranes of infected cells and has an envelope composed of glycoproteins, the H and F proteins, and lipids. The H and F proteins appear as short surface projections and are responsible for receptor binding and virus entry into susceptible cells (1). Three cell surface receptors for wild-type measles virus have been identified and all interact with the H glycoprotein (2). The M protein is positioned under the virion envelope and anchors the nucleocapsids to the budding sites at the plasma membrane. Unlike the H and F surface proteins, the M is neither glycosylated nor transmembranous. The envelope encloses an elongated helical nucleocapsid in which protein units are spirally arranged around the nucleic acid. The nucleoprotein (N), phosphoprotein, and large polymerase protein, in conjunction with the virion negative strand RNA, comprise the ribonucleoprotein complex, the replicating, and transcriptional unit of measles virus (1, 3). Although measles virus has only a single serotype, it can be subdivided into 24 distinct genotypes based on the sequence variability of the last 450 nucleotides of the N gene. These sequences can vary by up to 12% among the genotypes and form the basis of the molecular epidemiology applied to tracking of transmission pathways, monitoring control measures, and distinguishing wild-type viruses from vaccine strains of measles (4, 5).

Citation: Bellini W, Icenogle J, Hickman C. 2016. Measles, Mumps, and Rubella Viruses, p 293-310. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch21
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555819156.ch21
1. Lamb RA, Parks CL,. 2013. Paramyxoviridae, p 957–995. In Knipe DM, Howley PM (ed), Fields Virology, 6th ed, vol 1. Lippincott, Williams & Wilkins, Philadelphia.
2. Yanagi Y, Takeda M, Ohno S, Hashiguchi T. 2009. Measles virus receptors. Curr Top Microbiol Immunol 329:1330.[PubMed]
3. Rima BK, Duprex WP. 2009. The measles virus replication cycle. Curr Top Microbiol Immunol 329:77102.[PubMed]
4. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, Hübschen JM, Siqueira M, Beirnes J, Ahmed H, Triki H, Al-Busaidy S, Dosseh A, Byabamazima C, Smit S, Akoua-Koffi C, Bwogi J, Bukenya H, Wairagkar N, Ramamurty N, Incomserb P, Pattamadilok S, Jee Y, Lim W, Xu W, Komase K, Takeda M, Tran T, Castillo-Solorzano C, Chenoweth P, Brown D, Mulders MN, Bellini WJ, Featherstone D. 2011. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis 204(Suppl 1):S514S523.[PubMed]
5. Bankamp B, Byrd-Leotis LA, Lopareva EN, Woo GK, Liu C, Jee Y, Ahmed H, Lim WW, Ramamurty N, Mulders MN, Featherstone D, Bellini WJ, Rota PA. 2013. Improving molecular tools for global surveillance of measles virus. J Clin Virol 58:176182.[PubMed]
6. Xu P, Li Z, Sun D, Lin Y, Wu J, Rota PA, He B. 2011. Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus. Virology 417:126136.[PubMed]
7. Malik T, Shegogue CW, Werner K, Ngo L, Sauder C, Zhang C, Duprex WP, Rubin S. 2011. Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence. J Virol 85:60826085.[PubMed]
8. Jin L, Beard S, Brown DW. 1999. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis 180:829833.[PubMed]
9. Johansson B, Tecle T, Orvell C. 2002. Proposed criteria for classification of new genotypes of mumps virus. Scand J Infect Dis 34:355357.[PubMed]
10. Jin L, Örvell C, Myers R, Rota PA, Nakayama T, Forcic D, Hiebert J, Brown KE. 2015. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Rev Med Virol 25:85101.[PubMed]
11. Cooper LZ. 1985. The history and medical consequences of rubella. Rev Infect Dis 7(Suppl 1):S2S10.[PubMed]
12. Gregg NM. 1941. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3:3546.
13. Lee J-Y, Bowden DS. 2000. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 13:571587.[PubMed]
14. Abernathy E, Chen MH, Bera J, Shrivastava S, Kirkness E, Zheng Q, Bellini W, Icenogle J. 2013. Analysis of whole genome sequences of 16 strains of rubella virus from the United States, 1961–2009. Virol J 10:32.[PubMed]
15. Prasad VM, Willows SD, Fokine A, Battisti AJ, Sun S, Plevka P, Hobman TC, Rossmann MG. 2013. Rubella virus capsid protein structure and its role in virus assembly and infection. Proc Natl Acad Sci USA 110:2010520110.[PubMed]
16. Battisti AJ, Yoder JD, Plevka P, Winkler DC, Prasad VM, Kuhn RJ, Frey TK, Steven AC, Rossmann MG. 2012. Cryo-electron tomography of rubella virus. J Virol 86:1107811085.[PubMed]
17. DuBois RM, Vaney MC, Tortorici MA, Kurdi RA, Barba-Spaeth G, Krey T, Rey FA. 2013. Functional and evolutionary insight from the crystal structure of rubella virus protein E1. Nature 493:552556.[PubMed]
18. World Health Organization. 2013. Rubella virus nomenclature update: 2013. Wkly Epidemiol Rec 88:337343.[PubMed]
19. Zhu Z. , et al, Rubella Virology Surveillance Working Group. 2015. Evolutionary analysis of rubella viruses in mainland China during 2010–2012: endemic circulation of genotype 1E and introductions of genotype 2B. Sci Rep 5:7999.[PubMed]
20. Namuwulya P, Abernathy E, Bukenya H, Bwogi J, Tushabe P, Birungi M, Seguya R, Kabaliisa T, Alibu VP, Kayondo JK, Rivailler P, Icenogle J, Bakamutumaho B. 2014. Phylogenetic analysis of rubella viruses identified in Uganda, 2003–2012. J Med Virol 86:21072113.[PubMed]
21. Enders JF, Peebles TC. 1954. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 86:277286.[PubMed]
22. Schwarz AJ. 1962. Preliminary tests of a highly attenuated measles vaccine. Am J Dis Child 103:386389.[PubMed]
23. Centers for Disease Control. 1982. Countdown toward the elimination of measles in the U.S. MMWR Morb Mortal Wkly Rep 31:447478.
24. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L Centers for Disease Control. 1998. Measles, mumps, and rubella—vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 47(RR-8):157.[PubMed]
25. Watson JC, Redd SC, Rhodes PH, Hadler SC. 1998. The interruption of transmission of indigenous measles in the United States during 1993. Pediatr Infect Dis J 17:363366, discussion 366–367.[PubMed]
26. Rota JS, Heath JL, Rota PA, King GE, Celma ML, Carabaña J, Fernandez-Muñoz R, Brown D, Jin L, Bellini WJ. 1996. Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis 173:3237.[PubMed]
27. Katz SL, Hinman AR. 2004. Summary and conclusions: measles elimination meeting, 16–17 March 2000. J Infect Dis 189(Suppl 1):S43S47.[PubMed]
28. Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, Hao L, McLean HQ, Rota JS, Bellini WJ, Seward JF. 2014. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr 168:148155.[PubMed]
29. Gastañaduy PA, Redd SB, Fiebelkorn AP, Rota JS, Rota PA, Bellini WJ, Seward JF, Wallace GS Division of Viral Disease, National Center for Immunization and Respiratory Diseases, CDC. 2014. Measles—United States, January 1-May 23, 2014. MMWR Morb Mortal Wkly Rep 63:496499.[PubMed]
30. Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, Wallace GS Centers for Disease Control and Prevention (CDC). 2015. Measles—United States, January 4-April 2, 2015. MMWR Morb Mortal Wkly Rep 64:373376.[PubMed]
31. Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL Centers for Disease Control and Prevention (CDC). 2014. Progress toward regional measles elimination—worldwide, 2000–2013. MMWR Morb Mortal Wkly Rep 63:10341038.[PubMed]
32. Drexler JF, Corman VM, Müller MA, Maganga GD, Vallo P, Binger T, Gloza-Rausch F, Cottontail VM, Rasche A, Yordanov S, Seebens A, Knörnschild M, Oppong S, Adu Sarkodie Y, Pongombo C, Lukashev AN, Schmidt-Chanasit J, Stöcker A, Carneiro AJ, Erbar S, Maisner A, Fronhoffs F, Buettner R, Kalko EK, Kruppa T, Franke CR, Kallies R, Yandoko ER, Herrler G, Reusken C, Hassanin A, Krüger DH, Matthee S, Ulrich RG, Leroy EM, Drosten C. 2012. Bats host major mammalian paramyxoviruses. Nat Commun 3:796806.[PubMed]
33. Krüger N, Hoffmann Mm, Drexler JF, Müller MA, Corman VM, Sauder C, Rubin S, He B, Örvell C, Drosten C, Herrler G. 2015. Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus. J Virol 89:45394548.
34. Bitsko RH, Cortese MM, Dayan GH, Rota PA, Lowe L, Iversen SC, Bellini WJ. 2008. Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol 46:11011103.[PubMed]
35. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, Clayton J, Kightlinger LK, Dietle EG, Berg J, Kenyon CL, Goldstein ST, Stokley SK, Redd SB, Rota PA, Rota J, Bi D, Roush SW, Bridges CB, Santibanez TA, Parashar U, Bellini WJ, Seward JF. 2008. Recent resurgence of mumps in the United States. N Engl J Med 358:15801589.[PubMed]
36. Man W, Jin-Kou Z, Tao W, Li-Xin H, Chao M, Qi-Ru S, Hui-Ming L. 2012. Mumps-containing vaccine effectiveness during outbreaks in two schools in Guangdong, China, 2012. Western Pac Surveill Response J 3:2932.[PubMed]
37. Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. 2009. Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill 14:pii_19440.
38. Anderson RM. 1992. The concept of herd immunity and the design of community-based immunization programmes. Vaccine 10:928935.[PubMed]
39. Kutty PK, Kruszon-Moran DM, Dayan GH, Alexander JP, Williams NJ, Garcia PE, Hickman CJ, McQuillan GM, Bellini WJ. 2010. Seroprevalence of antibody to mumps virus in the US population, 1999–2004. J Infect Dis 202:667674.[PubMed]
40. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, Dayan GH. 2008. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 197:16621668.[PubMed]
41. Latner DR, McGrew M, Williams NJ, Sowers SB, Bellini WJ, Hickman CJ. 2014. Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method. Clin Vaccine Immunol 21:286297.[PubMed]
42. Parkman PD, Buescher EL, Artenstein MS. 1962. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med 111:225230.[PubMed]
43. Weller TH, Neva FA. 1962. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc Soc Exp Biol Med 111:215225.
44. Horstmann DM. 1975. Controlling rubella: problems and perspectives. Ann Intern Med 83:412417.[PubMed]
45. Reef SE, Cochi SL. 2006. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin Infect Dis 43(Suppl 3):S123S125.[PubMed]
46. Centers for Disease Control and Prevention. 2013. Three cases of congenital rubella syndrome in the postelimination era—Maryland, Alabama, and Illinois, 2012. MMWR Morb Mortal Wkly Rep 129:226229.
47. Reef SE, Frey TK, Theall K, Abernathy E, Burnett CL, Icenogle J, McCauley MM, Wharton M. 2002. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 287:464472.[PubMed]
48. Best JM, Icenogle JP, Brown DWG,. 2009. Rubella, p 561–592. In Zuckerman AJ, Banatvala JE, Schoub BD, Griffiths PD, Mortimer P (ed), Principles and Practice of Clinical Virology, 6th ed. Wiley-Blackwell, Singapore.
49. Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. 2015. Rubella. Lancet 385:22972307.[PubMed]
50. Mao B, Chheng K, Wannemuehler K, Vynnycky E, Buth S, Soeung SC, Reef S, Weldon W, Quick L, Gregory CJ. 2015. Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012. Epidemiol Infect 143:18581867.[PubMed]
51. Koplik H. 1962. The diagnosis of the invasion of measles from a study of the exanthema as it appears on the buccal mucous membrane. Arch Pediatr 79:162165.[PubMed]
52. Perry RT, Halsey NA. 2004. The clinical significance of measles: a review. J Infect Dis 189(Suppl 1):S4S16.[PubMed]
53. Gershon A, Krugman S,. 1979. Measles virus, p 665–693. In Lennette EH, Schmidt NJ (ed), Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. American Public Health Association, Washington, D.C.
54. Horta-Barbosa L, Fuccillo DA, Sever JL, Zeman W. 1969. Subacute sclerosing panencephalitis: isolation of measles virus from a brain biopsy. Nature 221:974.[PubMed]
55. Horta-Barbosa L, Hamilton R, Wittig B, Fuccillo DA, Sever JL, Vernon ML. 1971. Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies. Science 173:840841.[PubMed]
56. Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, Shieh W-J, Rota PA. 2005. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192:16861693.[PubMed]
57. Halsey NA, Modlin JF, Jabbour JT, Dubey L, Eddins DL, Ludwig DD. 1980. Risk factors in subacute sclerosing panencephalitis: a case-control study. Am J Epidemiol 111:415424.[PubMed]
58. Campbell H, Andrews N, Brown KE, Miller E. 2007. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 36:13341348.[PubMed]
59. Eberhart-Phillips JE, Frederick PD, Baron RC, Mascola L. 1993. Measles in pregnancy: a descriptive study of 58 cases. Obstet Gynecol 82:797801.[PubMed]
60. Manikkavasagan G, Ramsay M. 2009. The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review. J Obstet Gynaecol 29:572575.[PubMed]
61. Fulginiti VA, Eller JJ, Downie AW, Kempe CH. 1967. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202:10751080.[PubMed]
62. Markowitz LE, Chandler FW, Roldan EO, Saldana MJ, Roach KC, Hutchins SS, Preblud SR, Mitchell CD, Scott GB. 1988. Fatal measles pneumonia without rash in a child with AIDS. J Infect Dis 158:480483.[PubMed]
63. Sullivan KM, Halpin TJ, Kim-Farley R, Marks JS. 1985. Mumps disease and its health impact: an outbreak-based report. Pediatrics 76:533536.[PubMed]
64. Azimi PH, Cramblett HG, Haynes RE. 1969. Mumps meningoencephalitis in children. JAMA 207:509512.[PubMed]
65. Beard CM, Benson RC Jr, Kelalis PP, Elveback LR, Kurland LT. 1977. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clin Proc 52:37.[PubMed]
66. Casella R, Leibundgut B, Lehmann K, Gasser TC. 1997. Mumps orchitis: report of a mini-epidemic. J Urol 158:21582161.
67. Nickel WR, Plumb RT,. 1986. Orchitis, p 977. In Walsh PC, Gittes RF, Perlmutter AD, Stamey TA (ed), Campbell's Urology, 5th ed. WB Saunders Co, Philadelphia.
68. Plotkin SA. Commentary: mumps vaccines: do we need a new one? 2013. Pediatr Infect Dis J 32:381382.
69. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, Apostolou A, Blog D, Zimmerman CM, Montana B, Harpaz R, Hickman CJ, Rota PA, Rota JS, Bellini WJ, Gallagher KM. 2012. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 367:17041713.[PubMed]
70. Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, Lizama A, Diras D, Mathew A, Camacho EJ, Monforte MN, Chen TH, Mahamud A, Kutty PK, Hickman C, Bellini WJ, Seward JF, Gallagher K, Fiebelkorn AP. 2013. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control—Guam 2009 to 2010. Pediatr Infect Dis J 32:374380.[PubMed]
71. Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G. 2015. Characteristics of a large mumps outbreak: clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum Vaccin Immunother 11:14131417.[PubMed]
72. Philip RN, Reinhard KR, Lackman DB. 1959. Observations on a mumps epidemic in a virgin population. Am J Hyg 69:91111.[PubMed]
73. Hall R, Richards H. 1987. Hearing loss due to mumps. Arch Dis Child 62:189191.[PubMed]
74. Hashimoto H, Fujioka M, Kinumaki H Kinki Ambulatory Pediatrics Study Group. 2009. An office-based prospective study of deafness in mumps. Pediatr Infect Dis J 28:173175.[PubMed]
75. Kanra G, Kara A, Cengiz AB, Isik P, Ceyhan M, Ataş A. 2002. Mumps meningoencephalitis effect on hearing. Pediatr Infect Dis J 21:11671169.[PubMed]
76. Ratzmann KP, Strese J, Witt S, Berling H, Keilacker H, Michaelis D. 1984. Mumps infection and insulin-dependent diabetes mellitus (IDDM). Diabetes Care 7:170173.[PubMed]
77. Duderstadt SK,. Rose CE, Jr, Real TM, Sabatier JF, Stewart B, Ma G, Yerubandi UD, Eick AA, Tokars JI, McNeil MM. 2012. Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002–2008. Vaccine 30:813819.
78. Lund KD, Chantler JK. 2000. Mapping of genetic determinants of rubella virus associated with growth in joint tissue. J Virol 74:796804.[PubMed]
79. Abernathy E, Peairs RR, Chen M-H, Icenogle J, Namdari H. 2015. Genomic characterization of a persistent rubella virus from a case of Fuch’ uveitis syndrome in a 73 year old man. J Clin Virol 69:104109.[PubMed]
80. Webster WS. 1998. Teratogen update: congenital rubella. Teratology 58:1323.[PubMed]
81. Perelygina L, Zheng Q, Metcalfe M, Icenogle J. 2013. Persistent infection of human fetal endothelial cells with rubella virus. PLoS One 8:e73014.[PubMed]
82. Menser MA, Forrest JM, Honeyman MC, Burgess JA. 1974. Letter: Diabetes, HL-A antigens, and congenital rubella. Lancet 2:15081509.[PubMed]
83. Floret D, Rosenberg D, Hage GN, Monnet P. 1980. Case report: hyperthyroidism, diabetes mellitus and the congenital rubella syndrome. Acta Paediatr Scand 69(2):259261.
84. Boger WP III, Petersen RA, Robb RM. 1981. Spontaneous absorption of the lens in the congenital rubella syndrome. Arch Ophthalmol 99:433434.[PubMed]
85. Winchester SA, Varga Z, Parmar D, Brown KE. 2013. Persistent intraocular rubella infection in a patient with Fuchs’ uveitis and congenital rubella syndrome. J Clin Microbiol 51:16221624.[PubMed]
86. Townsend JJ, Stroop WG, Baringer JR, Wolinsky JS, McKerrow JH, Berg BO. 1982. Neuropathology of progressive rubella panencephalitis after childhood rubella. Neurology 32:185190.[PubMed]
87. Rosenberg HS, Oppenheimer EH, Esterly JR. 1981. Congenital rubella syndrome: the late effects and their relation to early lesions. Perspect Pediatr Pathol 6:183202.[PubMed]
88. Centers for Disease Control and Prevention. 2012. Congenital rubella syndrome, chapter 15. In Roush SW, Baldy LM (ed), Manual for the Surveillance of Vaccine-Preventable Diseases. U.S. Department of Health and Human Services, CDC, Atlanta, GA. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html.
89. American Academy of Pediatrics. 1997. A summary of major changes in the Red Book. In Peter G (ed), 1997 Red Book: Report of the Committee on Infectious Diseases, 24th ed. American Academy of Pediatrics, Elk Grove, IL.
90. Centers for Disease Control. 1989. Measles prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 38:117.[PubMed]
91. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS Centers for Disease Control and Prevention. 2013. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62(RR-04):134.[PubMed]
92. Hersh BS, Fine PE, Kent WK, Cochi SL, Kahn LH, Zell ER, Hays PL, Wood CL. 1991. Mumps outbreak in a highly vaccinated population. J Pediatr 119:187193.[PubMed]
93. Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, Schaffner W. 1994. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 169:7782.[PubMed]
94. Whitman C. 1999. Mumps outbreak in a highly vaccinated population. NY VAC SCENE 1[1]. The New York City Department of Health, New York, NY.
95. McNabb SJ, Jajosky RA, Hall-Baker PA, Adams DA, Sharp P, Anderson WJ, Javier AJ, Jones GJ, Nitschke DA, Worshams CA, Richard RA Jr Centers for Disease Control and Prevention (CDC). 2007. Summary of notifiable diseases—United States, 2005. MMWR Morb Mortal Wkly Rep 54:192.[PubMed]
96. Kyaw MH, Bellini WJ, Dayan GH. 2007. Mumps surveillance and prevention: putting mumps back on our radar screen. Cleve Clin J Med 74:1315.[PubMed]
97. Atrasheuskaya AV, Kulak MV, Rubin S, Ignatyev GM. 2007. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002–2004. Clin Microbiol Infect 13:670676.[PubMed]
98. LeBaron CW, Forghani B, Beck C, Brown C, Bi D, Cossen C, Sullivan BJ. 2009. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 199:552560.[PubMed]
99. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. 2008. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 197:950956.[PubMed]
100. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. 2007. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis 13:1217.[PubMed]
101. Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. 2004. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 22:27132716.[PubMed]
102. Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L, Kyaw MH, Baughman AL, Menitove JE, Hickman CJ, Bellini WJ, Dayan GH, Hansen GR, Rubin S. 2011. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis 204:14131422.[PubMed]
103. Nöjd J, Tecle T, Samuelsson A, Orvell C. 2001. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 19:17271731.[PubMed]
104. Rubin S, Mauldin J, Chumakov K, Vanderzanden J, Iskow R, Carbone K. 2006. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 24:26622668.[PubMed]
105. Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP. 2012. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 86:615620.[PubMed]
106. Gut JP, Lablache C, Behr S, Kirn A. 1995. Symptomatic mumps virus reinfections. J Med Virol 45:1723.[PubMed]
107. Yoshida N, Fujino M, Miyata A, Nagai T, Kamada M, Sakiyama H, Ihara T, Kumagai T, Okafuji T, Okafuji T, Nakayama T. 2008. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J Med Virol 80:517523.[PubMed]
108. Rubin S, Beeler J. 2013. Mumps vaccines: do we need a new one? Pediatr Infect Dis J 32:11561157.[PubMed]
109. Reef S, Plotkin SA,. 2007. Rubella vaccine, p 79–94. In Banatvala J, Peckham C (ed), Rubella Viruses, Perspectives in Medical Virology. Elsevier, Amsterdam, The Netherlands.
110. Castillo-Solórzano C, Reef SE, Morice A, Vascones N, Chevez AE, Castalia-Soares R, Torres C, Vizzotti C, Ruiz Matus C. 2011. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001–2008. J Infect Dis 204(Suppl 2):S713S717.[PubMed]
111. Centers for Disease Control and Prevention. 2013. Measles, p 1–21. In Roush SW, Baldy LM (ed), Manual for the Surveillance of Vaccine-Preventable Diseases, 6th ed. U.S. Department of Health and Human Services, CDC, Atlanta, GA.
112. Helfand RF, Heath JL, Anderson LJ, Maes EF, Guris D, Bellini WJ. 1997. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis 175:195199.[PubMed]
113. Woo GK, Wong AH, Lee WY, Lau CS, Cheng PK, Leung PC, Lim WW. 2010. Comparison of laboratory diagnostic methods for measles infection and identification of measles virus genotypes in Hong Kong. J Med Virol 82:17731781.[PubMed]
114. Tuokko H. 1984. Comparison of nonspecific reactivity in indirect and reverse immunoassays for measles and mumps immunoglobulin M antibodies. J Clin Microbiol 20:972976.[PubMed]
115. Erdman DD, Anderson LJ, Adams DR, Stewart JA, Markowitz LE, Bellini WJ. 1991. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol 29:14661471.[PubMed]
116. Mayo DR, Brennan T, Cormier DP, Hadler J, Lamb P. 1991. Evaluation of a commercial measles virus immunoglobulin M enzyme immunoassay. J Clin Microbiol 29:28652867.[PubMed]
117. Hummel KB, Erdman DD, Heath J, Bellini WJ. 1992. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol 30:28742880.[PubMed]
118. Samuel D, Sasnauskas K, Jin L, Gedvilaite A, Slibinskas R, Beard S, Zvirbliene A, Oliveira SA, Staniulis J, Cohen B, Brown D. 2003. Development of a measles specific IgM ELISA for use with serum and oral fluid samples using recombinant measles nucleoprotein produced in Saccharomyces cerevisiae. J Clin Virol 28:121129.[PubMed]
119. Arista S, Ferraro D, Cascio A, Vizzi E, di Stefano R. 1995. Detection of IgM antibodies specific for measles virus by capture and indirect enzyme immunoassays. Res Virol 146:225232.[PubMed]
120. Ratnam S, Tipples G, Head C, Fauvel M, Fearon M, Ward BJ. 2000. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol 38:99104.[PubMed]
121. Woods CR,. 2013. False-positive results for immunoglobulin M serologic results: explanations and examples, p 87–90. In Weinberg G, Woods RC (ed), Pediatric ID Consultant, Oxford University Press on behalf of the Pediatric Infectious Diseases Society. Oxford University Press, Oxford.
122. Bellini WJ, Helfand RF. 2003. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis 187(Suppl 1):S283S290.[PubMed]
123. Dietz V, Rota J, Izurieta H, Carrasco P, Bellini W. 2004. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas. Bull World Health Organ 82:852857.[PubMed]
124. Helfand RF, Kebede S, Gary HE Jr, Beyene H, Bellini WJ. 1999. Timing of development of measles-specific immunoglobulin IgM and IgG after primary measles vaccination. Clin Diagn Lab Immunol 6:178180.[PubMed]
125. Albrecht P, Herrmann K, Burns GR. 1981. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 3:251260.[PubMed]
126. Ratnam S, Gadag V, West R, Burris J, Oates E, Stead F, Bouilianne N. 1995. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbiol 33:811815.[PubMed]
127. Cohen BJ, Parry RP, Doblas D, Samuel D, Warrener L, Andrews N, Brown D. 2006. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay. J Virol Methods 131:209212.[PubMed]
128. Tuokko H. 1995. Detection of acute measles infections by indirect and mu-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J Med Virol 45:306311.[PubMed]
129. Narita M, Yamada S, Matsuzono Y, Itakura O, Togashi T, Kikuta H. 1996. Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection. Clin Diagn Lab Immunol 3:211215.[PubMed]
130. de Souza VA, Pannuti CS, Sumita LM, de Andrade Junior HF. 1997. Enzyme linked immunosorbent assay IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J Med Virol 52:275279.
131. Mercader S, Garcia P, Bellini WJ. 2012. Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings. Clin Vaccine Immunol 19:18101817.[PubMed]
132. Paunio M, Hedman K, Davidkin I, Valle M, Heinonen OP, Leinikki P, Salmi A, Peltola H. 2000. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect 124:263271.[PubMed]
133. Pannuti CS, Morello RJ, Moraes JC, Curti SP, Afonso AM, Camargo MC, Souza VA. 2004. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin Diagn Lab Immunol 11:119122.[PubMed]
134. Hickman CJ, Hyde TB, Sowers SB, Mercader S, McGrew M, Williams NJ, Beeler JA, Audet S, Kiehl B, Nandy R, Tamin A, Bellini WJ. 2011. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals. J Infect Dis 204(Suppl 1):S549S558.[PubMed]
135. Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ. 2011. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis 204(Suppl 1):S559S563.[PubMed]
136. Rosen JB, Rota JS, Hickman CJ, Sowers SB, Mercader S, Rota PA, Bellini WJ, Huang AJ, Doll MK, Zucker JR, Zimmerman CM. 2014. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clin Infect Dis 58:12051210.[PubMed]
137. Cohen BJ, Audet S, Andrews N, Beeler J WHO working group on measles plaque reduction neutralization test. 2007. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26:5966.[PubMed]
138. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. 2001. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75:43994401.[PubMed]
139. Zaki S, Bellini WJ,. 1997. Measles virus, p 233–245. In Connor DH, Chandler FW, Schwartz DA, Manz DJ, Lack EE (ed), Pathology of Infectious Diseases, vol 1. Appleton and Lange, Stamford, CT.
140. Nakayama T, Mori T, Yamaguchi S, Sonoda S, Asamura S, Yamashita R, Takeuchi Y, Urano T. 1995. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res 35:116.[PubMed]
141. Rota PA, Khan AS, Durigon E, Yuran T, Villamarzo YS, Bellini WJ. 1995. Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol 33:24852488.[PubMed]
142. Hummel KB, Lowe L, Bellini WJ, Rota PA. 2006. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J Virol Methods 132:166173.[PubMed]
143. Hübschen JM, Kremer JR, De Landtsheer S, Muller CP. 2008. A multiplex TaqMan PCR assay for the detection of measles and rubella virus. J Virol Methods 149:246250.[PubMed]
144. Hyde TB, Dayan GH, Langidrik JR, Nandy R, Edwards R, Briand K, Konelios M, Marin M, Nguyen HQ, Khalifah AP, O'leary MJ, Williams NJ, Bellini WJ, Bi D, Brown CJ, Seward JF, Papania MJ. 2006. Measles outbreak in the Republic of the Marshall Islands, 2003. Int J Epidemiol 35:299306.[PubMed]
145. Bellini WJ, Rota PA. 1998. Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis 4:2935.[PubMed]
146. Katz RS, Premenko-Lanier M, McChesney MB, Rota PA, Bellini WJ. 2002. Detection of measles virus RNA in whole blood stored on filter paper. J Med Virol 67:596602.[PubMed]
147. Oliveira SA, Siqueira MM, Camacho LA, Castro-Silva R, Bruno BF, Cohen BJ. 2003. Use of RT-PCR on oral fluid samples to assist the identification of measles cases during an outbreak. Epidemiol Infect 130:101106.[PubMed]
148. Jin L, Brown DWG, Ramsay MEB, Rota PA, Bellini WJ. 1997. The diversity of measles virus in the United Kingdom, 1992–1995. J Gen Virol 78:12871294.[PubMed]
149. Jayamaha J, Binns PL, Fennell M, Ferson MJ, Newton P, Tran T, Catton M, Robertson P, Rawlinson W. 2012. Laboratory diagnosis, molecular characteristics, epidemiological and clinical features of an outbreak of measles in a low incidence population in Australia. J Clin Virol 54:168173.[PubMed]
150. El Mubarak HS, De Swart RL, Osterhaus AD, Schutten M. 2005. Development of a semi-quantitative real-time RT-PCR for the detection of measles virus. J Clin Virol 32:313317.[PubMed]
151. Plumet S, Gerlier D. 2005. Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. J Virol Methods 128:7987.[PubMed]
152. Rota JS, Rosen JB, Doll MK, McNall RJ, McGrew M, Williams N, Lopareva EN, Barskey AE, Punsalang A Jr, Rota PA, Oleszko WR, Hickman CJ, Zimmerman CM, Bellini W.J. 2013. Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York City in 2009. Clin Vaccine Immunol 20:391396.
153. Krause CH, Molyneaux PJ, Ho-Yen DO, McIntyre P, Carman WF, Templeton KE. 2007. Comparison of mumps-IgM ELISAs in acute infection. J Clin Virol 38:153156.[PubMed]
154. Gut JP, Spiess C, Schmitt S, Kirn A. 1985. Rapid diagnosis of acute mumps infection by a direct immunoglobulin M antibody capture enzyme immunoassay with labeled antigen. J Clin Microbiol 21:346352.[PubMed]
155. Krause CH, Eastick K, Ogilvie MM. 2006. Real-time PCR for mumps diagnosis on clinical specimens—comparison with results of conventional methods of virus detection and nested PCR. J Clin Virol 37:184189.[PubMed]
156. Sakata H, Tsurudome M, Hishiyama M, Ito Y, Sugiura A. 1985. Enzyme-linked immunosorbent assay for mumps IgM antibody: comparison of IgM capture and indirect IgM assay. J Virol Methods 12:303311.[PubMed]
157. Davidkin I, Jokinen S, Paananen A, Leinikki P, Peltola H. 2005. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella. J Infect Dis 191:719723.[PubMed]
158. Barskey AE, Juieng P, Whitaker BL, Erdman DD, Oberste MS, Chern SW, Schmid DS, Radford KW, McNall RJ, Rota PA, Hickman CJ, Bellini WJ, Wallace GS. 2013. Viruses detected among sporadic cases of parotitis, United States, 2009–2011. J Infect Dis 208:19791986.[PubMed]
159. Utz JP, Kasel JA, Cramblett HG, Szwed CF, Parrott RH. 1957. Clinical and laboratory studies of mumps. I. Laboratory diagnosis by tissue-culture technics. N Engl J Med 257:497502.[PubMed]
160. Utz JP, Szwed CF, Kasel JA. 1958. Clinical and laboratory studies of mumps. II. Detection and duration of excretion of virus in urine. Proc Soc Exp Biol Med 99:259261.[PubMed]
161. Reina J, Ballesteros F, Ruiz de Gopegui E, Munar M, Mari M. 2003. Comparison between indirect immunofluorescence assay and shell vial culture for detection of mumps virus from clinical samples. J Clin Microbiol 41:51865187.[PubMed]
162. Chen M-H, Zhu Z, Zhang Y, Favors S, Xu WB, Featherstone DA, Icenogle JP. 2007.